Table 1.
Median duration and interquartile range (IQR) of hematotoxicity grade 3 or 4 episodes
| Lomustine-Temozolomide | Temozolomide | ||||
|---|---|---|---|---|---|
| n (%) | Median duration (IQR) | n (%) | Median duration (IQR) | p | |
| Leukopenia | 10 (15.2) | 9 (6 – 16) | 8 (12.7) | 9 (6–21) | 0.76 |
| Neutropenia | 8 (12.1) | 10.5 (8 – 14.75) | 4 (6.3) | 11 (5–21.5) | 0.95 |
| Thrombopenia | 19 (28.8) | 13 (4.25–20.5) | 15 (23.8) | 14.5 (5.5–31.75) | 0.46 |
| Lymphopenia | 3 (4.5) | 140 (90 – n.d.) | 4 (6.3) | 7 (6.5–21.5) | 0.024 |
| Anemia | 1 (1.5) | 2 (n.d. – n.d.) | 3 (4.8) | 12.5 (1 – n.d.) | 0.99 |